Get started
Author

Matthew Tolerico

Observed names: M. Tolerico, Matthew R. Tolerico
Institution: University of Miami
ORCID: 0000-0002-1891-1166
Observed ORCID: 0000-0002-1891-1166
OpenAlex ID: A5010274754
Activation of Stimulator of IFN Genes (STING) Causes Proteinuria and Contributes to Glomerular Diseases
2022 · Alla Mitrofanova, Antonio Fontanella, et al. · Journal of the American Society of Nephrology · 84
Expression of Acsm2, a kidney-specific gene, parallels the function and maturation of proximal tubular cells
2020 · Hirofumi Watanabe, Robert L. Paxton, et al. · American Journal of Physiology-Renal Physiology · 25
Normal and Dysregulated Sphingolipid Metabolism: Contributions to Podocyte Injury and Beyond
2024 · Matthew Tolerico, Sandra Merscher, et al. · Cells · 14
The enzyme SMPDL3b in podocytes decouples proteinuria from chronic kidney disease progression in experimental Alport Syndrome
2025 · Alla Mitrofanova, Antonio M. Fontanella, et al. · Kidney International · 7
Modulation of the Apolipoprotein M/S1PR4 Pathway Reduces Podocyte Lipid Overload in Alport Syndrome via Distinct Autophagy and Efflux Mechanisms
2025 · Matthew Tolerico, Judith Molina, et al. · Journal of the American Society of Nephrology · 3
PDF
Pos-345 Sting Activation Causes Proteinuria in Mice and Contributes to Glomerular Disease
2022 · A. MITROFANOVA, A. Fontanella, et al. · Kidney International Reports · 3
Apolipoprotein C-III Deficiency Mediates Podocyte Injury in Glomerular Diseases
2025 · Rachel Njeim, Haley Gye, et al. · Journal of the American Society of Nephrology
Inhibition of Sphingosine-1-Phosphate Receptor 4 (S1PR4) Improves Kidney Outcomes in a Mouse Model of Alport Syndrome via Inducing Lipophagy
2025 · Matthew Tolerico, Arianna Carrazco, et al. · Journal of the American Society of Nephrology
Inhibition of Sphingosine-1-Phosphate Receptor 4 Improves Renal Outcomes in a Mouse Model of Alport Syndrome
2024 · Matthew Tolerico, Arianna Carrazco, et al. · Journal of the American Society of Nephrology
Dysregulated Glomerular S1P Metabolism Contributes to Glomerular Injury
2024 · Antonio Miguel Fontanella, Matthew Tolerico, et al. · Journal of the American Society of Nephrology
APOM Deficiency Affects Kidney Function in an Experimental Mouse Model of Alport Syndrome
2024 · Judith T. Molina David, Matthew Tolerico, et al. · Journal of the American Society of Nephrology
Targeting Sphingosine-1-Phosphate Receptor 4 in a Mouse Model of Alport Syndrome
2023 · Matthew Tolerico, Judith T. Molina David, et al. · Journal of the American Society of Nephrology
Apolipoprotein M Treatment Restores Kidney Function in Mouse Model of Alport Syndrome
2023 · Judith T. Molina David, Matthew Tolerico, et al. · Journal of the American Society of Nephrology
SMPDL3b Regulates Proteinuria in Experimental Alport Syndrome via Sphingosin-1-Phosphate
2022 · Alla Mitrofanova, Annapurna Pamreddy, et al. · Journal of the American Society of Nephrology
SMPDL3b Modulates STING Activation in Podocytes
2022 · Matthew Tolerico, Antonio M. Fontanella, et al. · Journal of the American Society of Nephrology
Activation of STING Causes Proteinuria in Mice and Contributes to Diabetic Kidney Disease
2021 · Antonio M. Fontanella, Matthew Tolerico, et al. · Journal of the American Society of Nephrology
Works count: 16
Citation count: 136
H-index: 4
I10-index: 3
Year
Topic
Type